LifeNet Health
Industry
- Medical Devices
- Biomaterials
- Academic and Research Institutions
Other Names/Subsidiaries
- AlloTiss Gemeinnützige Gewebebank GmbH
- Vivo Biosciences, Inc.
- Samsara Sciences, Inc.
Latest on LifeNet Health
Bioventus Divests Wound Business To LifeNet Health To Enhance Liquidity Bioventus Inc. announced it signed a definite agreement to sell its wound care business to LifeNet Health for about $85m. Th
According to Informa’s Meddevicetracker report on “ Orthobiologics for Bone Repair and Regeneration ,” the global market for orthobiologics will see modest growth from $2.4bn in 2018 to $2.8bn in 2024
The global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, with a compound annual growth rate (CAGR) of 4.0%, according to "
The global market for orthobiologic products used in musculoskeletal soft tissue replacement and regeneration is expected to expand at a compound annual growth rate of 5.9% to reach $1.4bn by 2021. Ac